Rejuvenating Aging Frailty with MSCs Therapy | Dr David Greene R3 Stem Cell

1
REJUVENATING AGING FRAILTY WITH MESENCHYMAL STEM
CELL THERAPY
Dr. David Greene R3 Stem Cell
2
Mesenchymal Stem Cells (MSCs)
Mesenchymal stem cells (MSCs) are multipotent
stromal cells that can differentiate into a
variety of cell types, including osteoblasts
(bone cells), chondrocytes (cartilage cells),
myocytes (muscle cells) and adipocytes (fat
cells). They are found in many tissues, including
bone marrow, adipose tissue, umbilical cord, and
skin.
3
Aging Frailty
Aging frailty is a physical condition that is
associated with a progressive decline in physical
and cognitive function that occurs with advancing
age. It is characterized by a loss of muscle
mass, strength, and coordination, as well as an
increased risk of falls, fractures, and other
medical complications. It is a common problem in
the elderly population, and can lead to
disability and decreased quality of life.
4
Potential Benefits of MSC Therapy for Aging
Frailty

• Improved physical and cognitive performance
• Reduced risk of falls and fractures
• Improved immune system functioning
• Increased longevity

5
Advantages of MSC Therapy for Aging Frailty

• Reduced risk of adverse effects
• Improved safety profile
• Minimal invasiveness

6
Challenges of MSC Therapy for Aging Frailty

• Limited availability of MSCs
• Limited understanding of the long-term effects
• Difficulty in accurately assessing the efficacy
  of the therapy

7
Conclusion

• MSC therapy has the potential to improve physical
  and cognitive performance in aging frailty.
• Clinical studies have shown promising results.

8
Contact Support
239-263-8444
www.r3stemcell.com